Olink AB (publ) (OLK) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

Olink AB (publ) Revenue Highlights


Latest Revenue (Y)

$169.91M

Latest Revenue (Q)

$28.59M

Main Geography (Y)

UNITED STATES

Olink AB (publ) Revenue by Period


Olink AB (publ) Revenue by Year

DateRevenueChange
2023-12-31$169.91M21.49%
2022-12-31$139.85M47.25%
2021-12-31$94.97M75.66%
2020-12-31$54.07M29.68%
2019-12-31$41.69M-

Olink AB (publ) generated $169.91M in revenue during NA 2023, up 21.49% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Olink AB (publ) Revenue by Quarter

DateRevenueChange
2024-03-31$28.59M-58.73%
2023-12-31$69.27M56.89%
2023-09-30$44.15M49.99%
2023-06-30$29.44M7.21%
2023-03-31$27.46M-52.57%
2022-12-31$57.88M82.19%
2022-09-30$31.77M15.48%
2022-06-30$27.51M21.33%
2022-03-31$22.68M-48.09%
2021-12-31$43.68M118.70%
2021-09-30$19.97M12.92%
2021-06-30$17.69M29.79%
2021-03-31$13.63M-49.87%
2020-12-31$27.19M147.23%
2020-09-30$11.00M39.49%
2020-06-30$7.88M-1.43%
2020-03-31$8.00M-

Olink AB (publ) generated $28.59M in revenue during Q1 2024, up -58.73% compared to the previous quarter, and up 49.39% compared to the same period a year ago.

Olink AB (publ) Revenue Breakdown


Olink AB (publ) Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21
CHINA$9.65M$9.48M-
UNITED STATES$73.64M--
SWEDEN$15.43M$13.42M-
Rest of world$5.05M$11.78M$596.00K
JAPAN$7.00M$10.03M-
Americas$5.12M$133.03M$27.11M
EMEA (excluding Sweden)$53.71M$101.96M$26.61M
Sweden--$3.15M
Japan--$2.60M
China--$148.00K

Olink AB (publ)'s latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (43.42%), EMEA (excluding Sweden) (31.67%), SWEDEN (9.10%), CHINA (5.69%), JAPAN (4.13%), Americas (3.02%), and Rest of world (2.98%).

Olink AB (publ) Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
QGENQiagen$1.97B$458.80M
NEOGNeogen$924.22M$228.81M
GTHGenetron$650.71M$201.32M
BNRBurning Rock Biotech$537.43M$125.62M
LMDXLumiraDx$254.48M$21.00M
CSTLCastle Biosciences$219.79M$87.00M
OLKOlink AB (publ)$169.91M$28.59M
FONRFONAR$98.65M$25.72M
STIMNeuronetics$71.35M$16.45M
XGNExagen$52.55M$15.06M
ACRSAclaris Therapeutics$31.25M$2.40M
PMDPsychemedics$22.10M$5.36M
DRIODarioHealth$20.35M$6.25M
SERASera Prognostics$306.00K-

OLK Revenue FAQ


Olink AB (publ)'s yearly revenue for 2023 was $169.91M, representing an increase of 21.49% compared to 2022. The company's yearly revenue for 2022 was $139.85M, representing an increase of 47.25% compared to 2021. OLK's yearly revenue for 2021 was $94.97M, representing an increase of 75.66% compared to 2020.

Olink AB (publ)'s quarterly revenue for Q1 2024 was $28.59M, a -58.73% decrease from the previous quarter (Q4 2023), and a 4.12% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $69.27M, a 56.89% increase from the previous quarter (Q3 2023), and a 19.67% increase year-over-year (Q4 2022). OLK's quarterly revenue for Q3 2023 was $44.15M, a 49.99% increase from the previous quarter (Q2 2023), and a 38.97% increase year-over-year (Q3 2022).

Olink AB (publ)'s revenue growth rate for the last 3 years (2021-2023) was 78.90%, and for the last 5 years (2019-2023) was 307.52%.